Simultaneous fMRI-PET of the opioidergic pain system in human brain

NeuroImage

Volumn 102, Issue P2, 2014, Pages 275-282

  Wey, Hsiao Ying ^a   Catana, Ciprian ^a   Hooker, Jacob M ^a   Dougherty, Darin D ^a   Knudsen, Gitte M ^b   Wang, Danny J J ^c   Chonde, Daniel B ^a   Rosen, Bruce R ^a   Gollub, Randy L ^a   Kong, Jian ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hemodynamic response; Neurotransmission; Opioid receptor; Pain; Simultaneous MRI PET

Indexed keywords

DIPRENORPHINE; ENDORPHIN; OPIATE RECEPTOR; NARCOTIC ANTAGONIST; DIPRENORPHINE C 11; OPIATE; RADIOLIGAND; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BOLD SIGNAL; BRAIN BLOOD FLOW; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; MALE; NERVE CELL NETWORK; NEUROCHEMISTRY; NEUROTRANSMISSION; NOCICEPTION; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; PAIN; PAIN ASSESSMENT; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN SECRETION; SIGNAL TRANSDUCTION; THALAMUS; VOLUNTEER; YOUNG ADULT; BRAIN; BRAIN MAPPING; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; SCINTISCANNING; HEMODYNAMICS; MENTAL FUNCTION; NEUROIMAGING;

ADULT; BRAIN; BRAIN MAPPING; CORPUS STRIATUM; DIPRENORPHINE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NARCOTIC ANTAGONISTS; PAIN; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, OPIOID; THALAMUS; YOUNG ADULT;

EID: 84906263176     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2014.07.058     Document Type: Article

References (46)

1. 11C]-carfentanil and positron emission tomography (PET). Pain 2002, 99:589-598.
2. Catana C., Drzezga A., Heiss W.-D., Rosen B.R. PET/MRI for neurologic applications. J. Nucl. Med. 2012, 53:1916-1925.
3. Catana C., Wu Y., Judenhofer M.S., Qi J., Pichler B.J., Cherry S.R. Simultaneous acquisition of multislice PET and MR images: initial results with a MR-compatible PET scanner. J. Nucl. Med. 2006, 47:1968-1976.
4. Drzezga A., Souvatzoglou M., Eiber M., Beer A.J., Furst S., Martinez-Möller A., Nekolla S.G., Ziegler S., Ganter C., Rummeny E.J., Schwaiger M. First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses. J. Nucl. Med. 2012, 53:845-855.
5. 11C]raclopride: combined PET-microdialysis studies. J. Cereb. Blood Flow Metab. 1997, 17:932-942.
6. Falkenberg L.E., Westerhausen R., Specht K., Hugdahl K. Resting-state glutamate level in the anterior cingulate predicts blood-oxygen level-dependent response to cognitive control. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:5069-5073.
7. Fischl B., van der Kouwe A., Destrieux C., Halgren E., Ségonne F., Salat D.H., Busa E., Seidman L.J., Goldstein J., Kennedy D., Caviness V., Makris N., Rosen B., Dale A.M. Automatically parcellating the human cerebral cortex. Cereb. Cortex 2004, 14:11-22.
8. Gracely R., McGrath P., Dubner R. Validity and sensitivity of ratio scales of sensory and affective verbal pain descriptors: manipulation of affect by diazepam. Pain 1978, 5:19-29.
9. Greve D.N., Fischl B. Accurate and robust brain image alignment using boundary-based registration. NeuroImage 2009, 48:63-72.
10. Hagelberg N., Kajander J.K., Någren K., Hinkka S., Hietala J., Scheinin H. Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man. Synapse 2002, 45:25-30.
11. Henriksen G., Willoch F. Imaging of opioid receptors in the central nervous system. Brain 2008, 131:1171-1196.
12. Jenkins B.G. Pharmacologic magnetic resonance imaging (phMRI): imaging drug action in the brain. NeuroImage 2012, 62:1072-1085.
13. Jenkinson M., Bannister P., Brady M., Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. NeuroImage 2002, 17:825-841.
14. Jenkinson M., Beckmann C.F., Behrens T.E.J., Woolrich M.W., Smith S.M. FSL. NeuroImage 2012, 62:782-790.
15. Jenkinson M., Smith S. A global optimisation method for robust affine registration of brain images. Med. Image Anal. 2001, 5:143-156.
16. Jones A.K., Cunningham V.J., Ha-Kawa S.K., Fujiwara T., Liyii Q., Luthra S.K., Ashburner J., Osman S., Jones T. Quantitation of [11C]diprenorphine cerebral kinetics in man acquired by PET using presaturation, pulse-chase and tracer-only protocols. J. Neurosci. Methods 1994, 51:123-134.
17. Kong J., Gollub R.L., Polich G., Kirsch I., LaViolette P., Vangel M., Rosen B., Kaptchuk T.J. A functional magnetic resonance imaging study on the neural mechanisms of hyperalgesic nocebo effect. J. Neurosci. 2008, 28:13354-13362.
18. Kong J., Gollub R.L., Rosman I.S., Webb J.M., Vangel M.G., Kirsch I., Kaptchuk T.J. Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging. J. Neurosci. 2006, 26:381-388.
19. Kong J., Loggia M.L., Zyloney C., Tu P., LaViolette P., Gollub R.L. Exploring the brain in pain: activations, deactivations and their relation. Pain 2010, 148:257-267.
20. Kong J., Tu P.-c, Zyloney C., Su T.-p Intrinsic functional connectivity of the periaqueductal gray, a resting fMRI study. Behav. Brain Res. 2010, 211:215-219.
21. Kong J., White N.S., Kwong K.K., Vangel M.G., Rosman I.S., Gracely R.H., Gollub R.L. Using fMRI to dissociate sensory encoding from cognitive evaluation of heat pain intensity. Hum. Brain Mapp. 2006, 27:715-721.
22. Lancaster J.L., Rainey L.H., Summerlin J.L., Freitas C.S., Fox P.T., Evans A.C., Toga A.W., Mazziotta J.C. Automated labeling of the human brain: a preliminary report on the development and evaluation of a forward-transform method. Hum. Brain Mapp. 1997, 5:238-242.
23. Lancaster J.L., Tordesillas-Gutiérrez D., Martinez M., Salinas F., Evans A., Zilles K., Mazziotta J.C., Fox P.T. Bias between MNI and Talairach coordinates analyzed using the ICBM-152 brain template. Hum. Brain Mapp. 2007, 28:1194-1205.
24. Laruelle M. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J. Cereb. Blood Flow Metab. 2000, 20:423-451.
25. Leknes S., Tracey I. A common neurobiology for pain and pleasure. Nat. Rev. Neurosci. 2008, 9:314-320.
26. Liu C.H., Greve D.N., Dai G., Marota J.J.A., Mandeville J.B. Remifentanil administration reveals biphasic phMRI temporal responses in rat consistent with dynamic receptor regulation. NeuroImage 2007, 34:1042-1053.
27. Logan J., Fowler J.S., Volkow N.D., Wang G.J., Ding Y.S., Alexoff D.L. Distribution volume ratios without blood sampling from graphical analysis of PET data. J. Cereb. Blood Flow Metab. 1996, 16:834-840.
28. Louilot A., Le Moal M., Simon H. Differential reactivity of dopaminergic neurons in the nucleus accumbens in response to different behavioral situations. An in vivo voltammetric study in free moving rats. Brain Res. 1986, 397:395-400.
29. Luthra S.K., et al. Automated radiosyntheses of [6-O-methyl-11C]diprenorphine and [6-O-methyl-11C]buprenorphine from 3-O-trityl protected precursors. Appl. Radiat. Isot. 1994, 45(8):857-873.
30. Maarrawi J., Peyron R., Mertens P., Costes N., Magnin M., Sindou M., Laurent B., Garcia-Larrea L. Differential brain opioid receptor availability in central and peripheral neuropathic pain. Pain 2007, 127:183-194.
31. Martikainen I.K., Peciña M., Love T.M., Nuechterlein E.B., Cummiford C.M., Green C.R., Harris R.E., Stohler C.S., Zubieta J.-K. Alterations in endogenous opioid functional measures in chronic back pain. J. Neurosci. 2013, 33:14729-14737.
32. Melichar J.K., Nutt D.J., Malizia A.L. Naloxone displacement at opioid receptor sites measured in vivo in the human brain. Eur. J. Pharmacol. 2003, 459:217-219.
33. Muthukumaraswamy S.D., Evans C.J., Edden R.A.E., Wise R.G., Singh K.D. Individual variability in the shape and amplitude of the BOLD-HRF correlates with endogenous GABAergic inhibition. Hum. Brain Mapp. 2012, 33:455-465.
34. Northoff G., Walter M., Schulte R.F., Beck J., Dydak U., Henning A., Boeker H., Grimm S., Boesiger P. GABA concentrations in the human anterior cingulate cortex predict negative BOLD responses in fMRI. Nat. Neurosci. 2007, 10:1515-1517.
35. Poynton C., Chonde D., Sabunca M., Kong J., Gollub R.L., Hooker J.M., Catana C. Atlas-based segmentation of T1-weighted and Dute MRI for calculation of attenuation correction maps in PET-MRI of brain tumor patients. J. Nucl. Med. 2012, 2332.
36. Schmidt B.L., Tambeli C.H., Barletta J., Luo L., Green P., Levine J.D., Gear R.W. Altered nucleus accumbens circuitry mediates pain-induced antinociception in morphine-tolerant rats. J. Neurosci. 2002, 22:6773-6780.
37. 11C]raclopride binding potential after a nonpharmacological challenge. Synapse 2007, 61:707-714.
38. Shih Y.-Y.I., Chiang Y.-C., Shyu B.-C., Jaw F.-S., Duong T.Q., Chang C. Endogenous opioid-dopamine neurotransmission underlie negative CBV fMRI signals. Exp. Neurol. 2012, 234:382-388.
39. Smith S.M. Fast robust automated brain extraction. Hum. Brain Mapp. 2002, 17:143-155.
40. Sprenger T., Valet M., Boecker H., Henriksen G., Spilker M.E., Willoch F., Wagner K.J., Wester H.J., Tölle T.R. Opioidergic activation in the medial pain system after heat pain. Pain 2006, 122:63-67.
41. Tracey I., Bushnell M.C. How neuroimaging studies have challenged us to rethink: is chronic pain a disease?. J. Pain 2009, 10:1113-1120.
42. Tracey I., Mantyh P.W. The cerebral signature for pain perception and its modulation. Neuron 2007, 55:377-391.
43. Wagner K.J., Sprenger T., Kochs E.F., Tölle T.R., Valet M., Willoch F. Imaging human cerebral pain modulation by dose-dependent opioid analgesia: a positron emission tomography activation study using remifentanil. Anesthesiology 2007, 106:548-556.
44. Willoch F., Tölle T.R., Wester H.J., Munz F., Petzold A., Schwaiger M., Conrad B., Bartenstein P. Central pain after pontine infarction is associated with changes in opioid receptor binding: a PET study with 11C-diprenorphine. AJNR Am. J. Neuroradiol. 1999, 20:686-690.
45. Wu Y., Carson R.E. Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging. J. Cereb. Blood Flow Metab. 2002, 22:1440-1452.
46. Zubieta J.K., Smith Y.R., Bueller J.A., Xu Y., Kilbourn M.R., Jewett D.M., Meyer C.R., Koeppe R.A., Stohler C.S. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science 2001, 293:311-315.